Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Paras Health reported 60.38% overall employee attrition in Fiscal 2026, as nurse attrition rose to 81.82% despite a 5,315-person workforce in June 2026.
Paras Health received 43.63% of June 2026 quarterly revenue from government schemes and PSUs, where average receivable days reached 166.69.
Paras Health’s Srinagar and Kanpur hospitals posted a Rs 12.725 crore Fiscal 2026 operating EBITDA loss despite 107.95% revenue growth to Rs 143.809 crore.
Paras Healthcare Ltd. IPO opens Oct 21–23, 2026. The ₹1,450 crore offer includes ₹500 crore fresh issue and ₹950 crore OFS; listing is due Oct 28, 2026.
Zetwerk Manufacturing Businesses Ltd. IPO opens 15 Oct 2026 at ₹143–₹151. Issue size ₹5,012.33 crore includes ₹2,830 crore fresh issue and ₹2,182.33 crore OFS.
Shellz India Limited reported recurring lender-statement mismatches, including Rs 95.28 lakh of stock short reporting in fiscal 2026’s second quarter.
Shellz India Limited acquired 18,57,675 shares of Shellz Overseas in March 2026, bringing its food marketing and distribution subsidiary into the group.
Organized sector is forecast to grow 7.5% annually to Rs 8.10 lakh crore by FY30F, compared with 4.1% for unorganized producers.
Shellz India’s Rs 20.77 crore disputed statutory demands at June 30, 2026 accounted for most of Rs 24.87 crore contingent liabilities, up from Rs 4.55 crore in FY25.
Shellz India disclosed statutory filing delays across GST, labour, tax and RoC obligations, with a BEN-2 return filed 1,852 days late in March 2026.
Shellz India’s working-capital cycle reached 198 days in June 2026 as Rs 23 crore of IPO proceeds is earmarked for Fiscal 2027 requirements.
Shellz India Limited’s unsecured loans payable to Kapil Garg and Shalini Garg reached Rs 15.0082 crore at June 30, 2026, or 13.83% of borrowings.
Shellz India reported six operational-creditor insolvency petitions filed since 2019; five were withdrawn after settlement and one was dismissed by September 2026.
Shellz India Limited has disclosed 10 pending vendor payment claims, led by CVS Packaging’s Rs 1.88 crore MSMED Act petition seeking interim asset protection.
Shellz India faces four misbranding proceedings, while Fruit Jelly Pudding tested at 11% total soluble solids against the prescribed 65% minimum.
Shellz India says no bank or financial-institution loan was defaulted or restructured, but credit-history records show certain delayed principal or interest payments.